Niche US Assets Catch Fire: Inside the Latest Moves from Sezzle to Sol StrategiesGlobal Report·1 day ago, 04:17 AMPRPH+0.33%SEZL-11.33%
ProPhase Labs, Inc. 1Q 2026: Revenue $478K, EPS $(0.43) — 10-Q SummaryTradingView·Jun 30 at 04:01 PMPRPH+0.33%
PRPH: Net loss widened to $5.4 million amid revenue decline and ongoing liquidity challengesQuartr·Jun 30 at 03:53 PMPRPH+0.33%
ProPhase Labs Q1 FY26 operating loss widens to $5.4 million; revenue drops 64.29% to $0.5 millionPUBT·Jun 30 at 03:51 PMPRPH+0.33%
ProPhase Labs, Inc. FY 2025: Revenue $4.35M, EPS ($1.74) — 10-K SummaryTradingView·Jun 1 at 04:15 PMPRPH+0.33%
ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform | PRPH Stock NewsStockTitan·Apr 15 at 12:05 AMPRPH+0.33%IBB+0.79%
Medipharm Labs Earnings Call Highlights Global Growth PivotTip Ranks·Apr 4 at 07:21 PMIXJ+1.07%LABU-0.84%
ProPhase Labs Explores Strategic Options for BE-Smart TestTip Ranks·Feb 13 at 04:53 PMPBE-0.72%PRPH+0.33%
ProPhase Labs Issues Update on Crown Medical CollectionsTip Ranks·Jan 27 at 10:27 AMIDNA+0.40%IHF-0.71%
ProPhase Labs Secures Flexible $10 Million Equity FacilityTip Ranks·Jan 23 at 04:55 PMIHF-0.71%IHE+1.24%
